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We report here the use of human inflammation arrays to
study the inflammatory gene expression profile of TNF- - α
treated human SGBS adipocytes. Human preadipocytes
(SGBS) were induced to differentiate in primary culture, and
adipocyte differentiation was confirmed, using Oil Red O
staining. We treated the differentiated adipocytes with TNF- , α
and RNA from differentiated adipocytes with or without TNF-
treatment was hybridized to MWG human inflammation α
arrays to compare expression profiles. Eleven genes were up-
or down-regulated in TNF- -treated adipocytes. As revealed α
by array analysis, among 6 up-regulated genes, only eotaxin-1,
monocyte chemoattractant protein-1 (MCP-1), and vascular
cell adhesion molecule 1 isoform a precursor (VCAM1) were
confirmed by real-time polymerase chain reaction (PCR).
Similarly, among 5 down-regulated genes, only IL-1 family
member 5 (IL1F5), a disintegrin and metalloprotease with
thrombospondin motifs-1 preproprotein (ADAMTS1), fibronectin
1 isoform 1 preprotein (FN1), and matrix metalloproteinase 15
preprotein (MMP15) were confirmed by real-time PCR. There
was a substantial increase (50-fold) in eotaxin-1 in response
to TNF- . Taken together, we have identified several inflam α -
matory molecules expressed in SGBS adipocytes and dis-
covered molecular factors explaining the relationship between
obesity and atherosclerosis, focusing on inflammatory cyto-
kines expressed in the TNF- -treated SGBS cells. Further α
investigation into the role of these up- or down-regulated
cytokine genes during the pathological processes leading to the
development of atherosclerosis is warranted.
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INTRODUCTION
Adipose tissue is a storage organ for excess
energy in the form of triglycerides. Since the dis-
covery of leptin, numerous reports have been
published, describing adipose tissue as a multi-
functional organ that produces and secretes many
factors, acting in a paracrine and endocrine
manner.
1 Adipocytes secrete many protein signals
and factors, collectively known as adipocytokines
or adipokines. These adipokines include inflam-
matory molecules, such as leptin, resistin,
adiponectin, tumor necrosis factor- (TNF- ), α α
adipsin, interleukins (IL-1 , IL-6, IL-8, IL-10), β
plasminogen activator inhibitor-1 (PAI-1), hapto-
globin, C-reactive protein (CRP), and MCP-1.
2,3
The current view is that certain adipokines and
other factors produced and released by white
adipose tissue are responsible for the chronic in-
flammatory state of obesity, particularly the
visceral form. Reduction of fat mass correlates
with decreases in the serum levels of many of
these adipokines,
4 implying that approaches
designed to promote fat loss should be useful in
attenuating the proinflammatory milieu associated
with obesity. The concomitance of inflammation,
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hypertension, and dyslipidemia increases the
likelihood of type II diabetes and cardiovascular
disease.
5
TNF- regulates key components of fat metabo α -
lism, with a net effect of preventing fat deposition
through inhibition of lipogenesis, increased
lipolysis, and facilitation of adipocyte death by
apoptosis.
6 TNF- has been suggested as a media α -
tor of insulin resistance in obesity,
13 although
controversy surrounds the exact nature of this
proposed role. The effects of TNF- and other α
proinflammatory cytokines on feeding, energy
balance, and neuroendocrine and immune func-
tion during infection and inflammation are well-
recognized.
7
It is likely that more inflammatory adipokines
will be discovered. Most studies on adipocyte-
secreted molecules have been conducted, using
3T3-L1 cells originating from mice, but recently
Simpson-Golabi-Behmel Syndrome (SGBS) human
preadipocytes have been introduced. These cells
can be induced to differentiate into adipocytes in
primary culture, enabling human adipocyte-
secreted molecules to be studied.
8
In this study, we describe the utilization of
MWG human inflammatory microarrays to study
the inflammatory gene expression profile of
human SGBS adipocytes. We also studied the
inflammatory gene expression profile of SGBS
cells following TNF- treatment. α
MATERIALS AND METHODS
SGBS cell culture
Cells were obtained from Dr. M. Wabitsch
(Univ. of Ulm, Ulm, Germany),
8 and these cells
were derived from the stromal cell fraction of
subcutaneous adipose tissue of an infant with
SGBS. The cells were grown in serum-containing
DMEM/F12 medium (Invitrogen, Paisley, UK),
supplemented with 33 mM biotin, 17 mM
pantothenate, and antibiotics. To induce adipocyte
differentiation, cells were washed with phosphate
buffered saline (PBS) buffer and cultured in
serum-free medium (DMEM/F12), supplemented
with 10 g/mL of transferrin, 10 μ nM insulin, 200
pM triiodothyronine, 1 M cortisol, 2 μ M BRL μ
49653, 500 M 1-methyl-3-isobutylxanthine μ (IBMX),
and 0.25 M dexamethasone for four days. After
four days, the medium was replaced with serum-
free medium (DMEM/F12), supplemented with 10
g/mL of transferrin, 10 μ nM insulin, 200 pM
triiodothyronine, and 1 M cortisol, and then μ
changed twice per week. One day before sample
treatment, the medium was changed to serum-free
medium, supplemented with only transferrin,
pantothenate, and biotin, and, the next day, cells
were treated with 50 ng of TNF- for 24 α h. All
materials except DMEM/F12 were from Sigma
(Poole, UK).
Oil Red O staining
Cells were fixed with 10% fresh formaldehyde
(Sigma, Poole, UK). They were rinsed in PBS
(Biowhittaker Molecular Application, Walkerville,
MD, USA), incubated with filtered Oil Red O
stock solution for at least 1 h, gently washed
twice with water, stained with 1 mL of Harris'
Haematoxylin (Brainwood lab., E. Sussex, UK),
and finally washed with warm distilled water.
cRNA preparation and probe preparation
RNA extraction and cDNA synthesis
Total RNA was extracted, using a standard
Trizol RNA isolation protocol (Life Technologies,
Grand Island, NY, USA) and quantified specto-
photometrically. To each 2 g total RNA sample, μ
1 L of 10 μ M oligo-dT μ (24) was added, and the
mixture was denatured at 70 for 2 min, then
immediately placed on ice. The reverse transcrip-
tion mastermix (2 L of 5X first strand buffer, 1 μ L μ
of 20 mM DTT, 1 L of 10 μ mM dNTP, and 1 L of μ
Powerscript reverse transcriptase {Clontech, BD
Biosciences, Oxford, UK}) was then added and
incubated for 1 h at 42 . Enzymic activity was
stopped by heating to 72 for 10 min.
cRNA amplification and labelling
Total RNA was extracted and reverse tran-
scribed as described above, except that the CDS
oligo-dT was replaced with a modified oligo-dT
with the T7 promotor sequence incorporated. The
first strand cDNA product was subjected to two
rounds of PCR amplification, using the SMARTInflammatory Gene Expression in SGBS Adipocytes
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protocol (Clontech, BD Biosciences, Oxford, UK).
The resulting dsDNA product was used in a
reaction with ribonucleotides and T7 RNA
polymerase and then incubated at 37 for 18 h.
Amplified cRNA was labeled with either Cy3 or
Cy5 dye, using a Micromax kit (PerkinElmer,
London, UK).
Hybridization and image processing
10 g labeled cRNA was dried in a Speedvac μ
and resuspended in 40 L hybridization buffer μ
(MWG Biotech AG, London, UK). The cRNA was
denatured at 95 for 3 min, vortexed, and briefly
spun-down to collect the contents. The cRNA was
chilled on ice for 30 sec and pipetted onto the
MWG human inflammatory array (MWG Biotech
AG). A coverslip was carefully placed on the
microarray, which was then sealed in the hybridi-
zation chamber and placed into an incubator at 42
overnight. Microarrays were subjected to 5 min
washes in 2X SSC, 0.1% SDS followed by 1X SSC,
and, finally, 0.1X SSC. The microarrays were
scanned at a resolution of 10 m, using an μ
Affymetrix 428 confocal laser scanner. The
microarray images were analyzed using Imagene
(Biodiscovery, CA, USA). Signal and background
means for both Cy3 and Cy5 channels were
calculated for each individual spot. These results
were then imported into Genesight (Biodiscovery,
CA, USA). The microarrays were corrected by
local background correction, which involves sub-
tracting each spot's background from the signal
value of the same spot. All of the genes in our
dataset were used to calculate normalization
parameters. Using all genes assumes that the
majority of the genes measured are not differ-
entially regulated. Therefore, when taken as a
whole, the population accurately represents the
channel bias.
Data analysis
Biodiscovery Genesights 4 (Biodiscovery, CA,
USA) was used for the analysis of the data. The
data for each of four signals (mean, four signals)
were combined and analyzed. All of the data was
corrected for background intensity, using local
background correction, and multiple spots with
flags were omitted. Normalization was performed,
using Lowess normalization, with a smoothing
parameter of 0.2 and one degree of fitness. Genes
that were two-fold up- or down-regulated were
partitioned with 95% confidence intervals.
Real-time polymerase chain reaction (PCR)
analysis
In a LightCycler (Roche Applied Science. India-
napolis, IN, USA), 1 L from 5 μ L of each reverse- μ
transcribed reaction was amplified in a 20 L PCR μ
mix, containing 4 mM MgCl2, 10 pM each primer,
and 1x LightCycler DNA Master SYBR Green 1 mix
(Roche Applied Science. Indianapolis, IN, USA).
Samples were incubated for an initial denaturation
at 94 for 30 s, followed by 40 PCR cycles. Each
cycle consisted of 95 for 10 s, each annealing
temperature for 5 s, and 72 for 12 s. For the
analysis of up- and down-regulated genes, PCR
primers, scanning exon-intron boundaries were
designed using Primer Premier 5 software (Biosoft
International, Palo Alto, CA, USA) and were manu-
factured by Bioneer (Bioneer, Daejeon, Korea). The
oligonucleotide primers for the experiment are
listed in Table 1. To confirm the amplification of
specific transcripts, melting curve profiles (cooling
the sample to 65 for 15 s and heating slowly to
95 with continuous measurement of fluores-
cence) were produced at the end of each PCR.
RESULTS
Inflammatory gene expression profile of TNF- - α
treated SGBS cells using inflammatory human
array
Differentiated SGBS cells were stained with Oil
Red O staining 0, 4, 10, and 20 days after the
induction of differentiation. Most of the cells were
differentiated as adipocytes and filled with lipid
droplets at Day 20 after the induction of differen-
tiation (Fig. 1).
In order to study the effect of a pro-inflam-
matory cytokine on the gene expression profile of
human SGBS cells, we treated differentiated SGBS
adipocytes with TNF- , which has a well-charac α -
terized effect in adipocytes. In this study, weMyoung-Sool Do, et al.
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replaced the medium of adipocytes on Day 18
with cortisol-free medium and incubated the
culture with TNF- for 24 h on Day 19. The cells α
were harvested on Day 20, and the gene expres-
sion profiles were analyzed using the inflam-
matory human arrays. From the 136 inflamma-
tory genes present on the arrays, a total of 42
genes were expressed at either day 20 or day 20/
TNF- (Fig. 2). Of these, 11 genes were two- fold α
up- or down-regulated. In TNF- -treated SGBS α
adipocytes, 6 genes were up-regulated, and 5
genes were down-regulated (Table 2). The up-
regulated genes were: regulator of g-protein sig-
naling 2 (RGS2), Tumor necrosis factor (ligand)
superfamily, member 13b (TNFSF13B), cholesterol
25-hydroxylase (CH25H), eotaxin-1, MCP-1, and
vascular cell adhesion molecule 1 isoform a pre-
cursor (VCAM1). The down-regulated genes were:
IL-1 family member 5 (IL1F5), a disintegrin and
metalloprotease with thrombospondin motifs-1
preproprotein (ADAMTS1), fibronectin 1 isoform
1 preprotein (FN1), matrix metalloproteinase 15
preprotein (MMP15), and prostaglandin e syn-
thase (PTGES).
Real-time PCR analysis of up- and down-
regulated genes of TNF- -treated SGBS cells α
The expression profiles found in the microarray
experiments of TNF- -treated SGBS cells were re α -
examined by real-time PCR with custom designed
primers for candidate genes (Table 1). Of the 6
genes shown through array analysis to be up-regu-
lated, only 3 genes, MCP-1, eotaxin-1, and VCAM1,
were also shown by real-time PCR to be up-regu-
lated. Of the 5 genes revealed by array analysis to
be down-regulated, 4 genes, IL1F5, MMP15, FN1,
and ADAMTS1, were found also by real-time PCR
to be down-regulated. PTGES was not down-regu-
lated according to either method (Table 3).
Table 1. Primer Sequences for Real-Time PCR
Candidate genes Forward primer
Reverse primer
RGS2: Regulator of g-protein signaling 2 5'-CAA CTG CCC AGA AAA GGG TA-3'
5'-ATG GCA GGT CAC AGT CCT TC-3'
TNFSF13B: Tumor necrosis factor (ligand) superfamily, member 13b 5'-ATG CAG AAA GGC AGA AAG GA-3'
5'-AAG GCA AGA AGT AAG GCG TGA-3'
CH25H: Cholesterol 25-hydroxylase 5'-TGG CAA CGC AGT ATA TGA GC-3'
5'-AGG GAA GTT GTA GCC GGA GT-3'
Eotaxin-1: A potent eosinophil chemoattractant 5'-AGA AAC CAC CAC CTC TCA CGC-3'
5'-CAC AGC TTT CTG GGG ACA TT-3'
MCP-1: Monocyte chemoattractant protein-1 5'-GCC TCC AGC ATG AAA GTC TC-3'
5'-CAG ATC TCC TTG GCC ACA ATG-3'
VCAM1: Vascular cell adhesion molecule 1
isoform a precursor
5'-TCC GTC TCA TTG ACT TGC AGC ACC-3'
5'-CAC CTG GAT TCC TTT TTC CA-3'
IL1F5: Interleukin 1 family, member 5 5'-GCG GGG AAG ACT ATG TAA A-3'
5'-AAG GTT TCA GCA GAG CCG TTA-3'
ADAMTS1: A disintegrin and metallo-protease with
thrombospondin motifs-1 preproprotein
5'-CTT TGC GCT GGA AGA AAA AC-3'
5'-ACG GAG CGA GGG AGC TTT AGT T-3'
FN1: Fibronectin 1 isoform 1 preproprotein 5'-CCA ACC TAC GGA TGA CTC GTG CT-3'
5'-GCT CAT CAT CTG GCC ATT TT-3'
MMP15: Matrix metalloproteinase 15 preproprotein 5'-CGT GTC CTG CTT TAC TGC AAG-3'
5'-AGT CGG GGA AAC AGA AAC AAA-3'
PTGES: Prostaglandin E synthase 5'-CAT GTG AGT CCC TGT GAT GGC-3'
5'-CTG CAG CAA AGA CAT CCA AA-3'
GAPDH: Glyceraldehydes-3-phosphate dehydrogenase 5'-GAG TCA ACG GAT TTG GTC GT-3'
5'-TGA CAA GCT TCC CGT TCT CAG-3'Inflammatory Gene Expression in SGBS Adipocytes
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DISCUSSION
The present study shows that treatment of dif-
ferentiated SGBS cells with the pleiotropic pro-
inflammatory cytokine, TNF- , increased expres α -
sion of six, and decreased the expression of five,
inflammation-related genes. Real-time PCR an-
alysis did not always confirm the results from
array analysis, and reason for this discrepancy
may be the cross-hybridization of oligonucleotides
Fig. 1. Oil Red O staining of SGBS
cells at (A) Day 0 and at (B) Day 4,
(C) Day 10, and (D) Day 20 after
differentiation. The stained lipid
droplets are shown in red.
B
A B
D C
A
Fig. 2. Scanned image data of a MWG
human inflammatory array, hybrid-
ized with cRNA prepared from dif-
ferentiated SGBS (Day 20) and TNF- - α
treated differentiated SGBS cells (Day
20/TNF- ). (A) Day 20 cells are Cy3- α
labeled and Day 20/TNF- cells are α
Cy5-labeled. (B) Day 20 cells are Cy5-
labeled and Day 20/TNF- cells are α
Cy3-labeled.Myoung-Sool Do, et al.
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in the array with other RNA. It is known that
cross-hybridization can give a false high signal for
some highly homologous gene sequences.
MCP-1 is a member of the chemokine family. In
vitro studies suggest that MCP-1 may contribute
to the development of insulin resistance and in-
duce adipocyte dedifferentiation.
9 In other studies,
MCP-1 mRNA expression has increased in obese
mice, leading to elevated levels of plasma MCP-1
protein. The higher levels of MCP-1 protein in
plasma were found to increase the CD11b-positive
monocyte/macrophage population among pe-
ripheral blood cells, suggesting a role for elevated
MCP-1 in the vascular inflammatory process
during atherosclerosis.
10 Eotaxin-1 is a potent
eosinophil chemoattractant that is abundant in
atheromatous plaques.
11 The major receptor for
eotaxin-1 is CCR3, which is found on leukocytes
and on some non-leukocytic cells. The expression
of eotaxin-1 in human adipocytes has not yet been
reported. Inflammatory cytokines induce endothe-
lial VCAM1 expression, a response known to be
augmented by either TRL or saturated FA.
12 Con-
sistent with these reports, it is demonstrated that
VLDL and palmitic FA (16:0) both significantly
increased VCAM1 mRNA in EC in the presence
of TNF- . α
Atherosclerosis involves pathological processes
that include athermanous plaque formation, foam
cell differentiation, inflammatory reactions, and
cell proliferation. Endothelial cell activation by
various inflammatory stimuli, including TNF- , α
increases the adherence of monocytes, a crucial
step in the development of vascular diseases. The
expression of endothelial adhesion molecules, in-
cluding vascular cell adhesion molecule-1, endo-
thelial-leukocyte adhesion molecule-1, and intra-
cellular adhesion molecule-1, plays a pivotal role
in monocyte adhesion to the arterial endothe-
lium.
13 The expression of MCP-1, eotaxin-1, and
VCAM1 in TNF- -treated SGBS cells demon α -
strates that adipocytes secrete the molecules
involved in atherosclerosis upon proinflammatory
cytokine treatment, implying that the proinflam-
matory cytokine production of overweight sub-
jects might be involved in the development of
atherosclerosis.
Among these down-regulated genes in this
study, ADAMTS1 and MMP15 are metallopro-
teinases that degrade extracellular matrix macro-
molecules and play important roles in tissue
remodeling under many physiological and
pathological conditions.
14 Fibronectin (FN) is a
major component of the extracellular matrix,
where it is assembled from insoluble polymers
and present in the blood as a soluble dimer.
15 It
has been reported that ADAMTS1 has ag-
grecanase activity and that its activity is enhanced
Table 2. Up- or Down-Regulated Genes of Day 20/TNF- -treated SGBS Cells α
Regulation Gene name Description
UP RGS2 Regulator of g-protein signaling 2
TNFSF13B Tumor necrosis factor (ligand) superfamily, member 13b
CH25H Cholesterol 25-hydroxylase
Eotaxin-1 A potent eosinophil chemoattractant
MCP-1 Monocyte chemoattractant protein-1
VCAM1 Vascular cell adhesion molecule 1 isoform a precursor
DOWN IL1F5 Interleukin 1 family, member 5
ADAMTS1
A disintegrin and metallo-protease with thrombospondin motifs-1
preproprotein
FN1 Fibronectin 1 isoform 1 preproprotein
MMP15 Matrix metalloproteinase 15 preproprotein
PTGES Prostaglandin E synthaseInflammatory Gene Expression in SGBS Adipocytes
Yonsei Med J Vol. 47, No. 5, 2006
in cartilage treated with TNF- , retinoic acid, and α
45 kDa fibronectin fragments.
16,17 It has also been
reported that the expression of several MMPs is
elevated in cartilage and synovial tissues of
patients with rheumatoid arthritis and osteoar-
thritis.
18,19 There have been a few reports that
ADAMTS1 and fibronectin are expressed in
adipocytes, but their function in adipocytes is not
Table 3. Real-Time PCR Analysis of Up- and Down-Regulated Genes of TNF- -treated, Differentiated SGBS Cells α
A) Up-regulated genes
Name Average CT CT CT 2
- CT ΔΔ
D20 VCAM 29.35 2.90 0 1
MCP-1 31.70 5.25 0 1
Eotaxin-1 32.65 6.20 0 1
CH25 29.00 2.55 0 1
TNFSF13B 30.45 4.00 0 1
RGS2 32.25 5.80 0 1
GAPDH 26.45 - - -
D20//TNF-α VCAM1 27.45 1.10 -1.80 3.48
MCP-1 26.00 -0.35 -5.60 48.50
Eotaxin-1 30.10 3.75 -2.45 5.46
CH25 30.95 4.60 2.05 0.24
TNFSF13B 32.45 6.10 2.10 0.23
RGS2 32.90 6.55 0.75 0.59
GAPDH 26.35 - - -
B) Down-regulated genes
Name Average CT CT CT 2
- CT ΔΔ
D20 IL1F5 30.80 8.05 0 1
ADAMTS 30.20 7.45 0 1
FN1 22.10 -0.65 0 1
MMP15 26.40 3.65 0 1
PTGES 26.45 3.70 0 1
GAPDH 22.75 - - -
D20/TNF-α IL1F5 33.25 11.55 3.50 0.089
ADAMTS 30.00 8.30 0.85 0.550
FN1 21.95 0.25 0.90 0.500
MMP15 29.10 7.40 3.75 0.074
PTGES 22.65 0.95 -2.75 6.730
GAPDH 21.70 - - -
CT, Avg.sample CT-Avg.GAPDH CT; CT, Avg. CT-Avg. CT, before; 2
- CT, normalized sample (after) amount relative to
sample (before).Myoung-Sool Do, et al.
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yet known.
20,21 Perhaps adipocyte accumulation
initiates an imbalance between matrix synthesis
and degradation in healthy cartilage, which, in
turn, promotes chondral loss and prevents carti-
lage self-repair.
IL1F5, a member of the IL-1 family, is relatively
abundant in epithelia and may help regulate
inflammation in this specific compartment.
22 The
role of IL1F5, ADAMTS1, FN1, and MMP15 in
adipocytes and the reason for their decrease after
TNF- treatment, are unknown at the moment α
and await further investigation.
In conclusion, we identified several inflamma-
tory molecules, newly expressed in SGBS
adipocytes, and also found molecular factors that
explain the relationship between obesity and
atherosclerosis, with a focus on the inflammatory
cytokines expressed by TNF- -treated SGBS cells. α
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